Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Genentech targets Lucentis BLA filing for December

Sep. 9, 2005

No Comments

Mycophenolate mofetil shows promise in the treatment of inflammatory eye disease

Sep. 9, 2005

No Comments

Recent Allergan patent reports new treatments for glaucoma

Sep. 7, 2005

No Comments

Isis grants iCo license for ISIS-13650 for eye diseases

Aug. 29, 2005

No Comments

Nevanac approved for pain and inflammation related to cataract surgery

Aug. 25, 2005

No Comments

Akorn signs agreement for AK-1015

Aug. 18, 2005

No Comments

Novel antiglaucoma agents jointly disclosed by Ube and Santen

Aug. 18, 2005

No Comments

TargeGen selects TG-100801 for clinical development

Aug. 2, 2005

No Comments

Progress in NicOx ophthalmology collaboration with Pfizer

July 27, 2005

No Comments

Allergan to evaluate Pharmacopeia compounds in models of ocular disease

July 15, 2005

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Genentech targets Lucentis BLA filing for December

Mycophenolate mofetil shows promise in the treatment of inflammatory eye disease

Recent Allergan patent reports new treatments for glaucoma

Isis grants iCo license for ISIS-13650 for eye diseases

Nevanac approved for pain and inflammation related to cataract surgery

Akorn signs agreement for AK-1015

Novel antiglaucoma agents jointly disclosed by Ube and Santen

TargeGen selects TG-100801 for clinical development

Progress in NicOx ophthalmology collaboration with Pfizer

Allergan to evaluate Pharmacopeia compounds in models of ocular disease

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

AI drives financings, approvals for APAC med-tech in 2024

Ocular RSS

Ocular
RSS